Omega-3 Fatty Acid and Colorectal Adenoma
Launched by DONGGUK UNIVERSITY · May 21, 2024
Trial Information
Current as of March 13, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients aged more than 40 years of age, scheduled for elective colonoscopy.
- Exclusion Criteria:
- • inflammatory bowel diseases
- • history of colorectal neoplasms
- • prior gastrointestinal surgery
- • substance abuse including alcohol
- • an inability to complete the survey due to emergency endoscopy
- • cognitive impairments and those undergoing significant dietary modifications
Trial Officials
Yun Jeong Lim
Principal Investigator
DongGuk University
About Dongguk University
Dongguk University is a prestigious institution dedicated to advancing medical research and education. With a commitment to innovative healthcare solutions, the university actively sponsors clinical trials aimed at enhancing patient outcomes and contributing to the scientific community. Leveraging its state-of-the-art facilities and a multidisciplinary team of experts, Dongguk University fosters collaboration between researchers, clinicians, and industry partners to explore novel therapies and improve clinical practices. The university's focus on ethical conduct and rigorous scientific methodology ensures the integrity and reliability of its research initiatives, making it a key player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Goyang Si, Gyeonggi Province, Korea, Republic Of
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
